Phoenix SENOLYTIX
Houston, US · 1 known investors
Phoenix SENOLYTIX is a longevity biotech developing controllable gene therapies that target the biological mechanisms of aging, based on its ApoptiCIDe-CE and ApoptiCIDe-RGT platforms and a proprietary cell-elimination switch triggered by a reformulated small molecule. Its programs aim to eliminate senescent cells and adipocytes and to regulate gene-therapy-delivered proteins for aging-related disorders and cancer.
BiotechHealthtechLongevity